ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2024

Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients.

Alyssa A Toorop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.